p16INK4a Expression, human papillomavirus, and survival in head and neck cancer

医学 免疫组织化学 内科学 头颈部癌 肿瘤科 阶段(地层学) 人乳头瘤病毒 癌症 组织学 生存分析 比例危险模型 生物 古生物学
作者
Elaine Smith,Donghong Wang,Yoonsang Kim,Linda M. Rubenstein,John H. Lee,Thomas H. Haugen,Lubomír P. Turek
出处
期刊:Oral Oncology [Elsevier BV]
卷期号:44 (2): 133-142 被引量:95
标识
DOI:10.1016/j.oraloncology.2007.01.010
摘要

Development of head and neck cancer (HNC) is associated with human papillomavirus high-risk (HPV-HR) types. The HPV E7 oncoprotein inactivates the pRB protein increasing expression of p16(INK4a). P16 expression and HPV status have been associated with differences in clinical outcomes for HNC. This study examined whether HNC prognosis was different when these biomarkers were examined as individual or joint molecular effects. Tumor tissue from 301 HNC patients were analyzed and sequenced for HPV types. P16 was evaluated by immunohistochemical staining. p16 was expressed in 35% and HPV-HR was detected in 27% of HNC patients. After adjustment for age, tobacco, and alcohol, p16+ tumors were statistically significantly associated with HPV-HR (OR=13.3, 7.1-24.9), histology, stage, grade, tumor site, and node involvement. Compared to p16+ HNC cases, those who did not express p16 had significantly worse disease-specific (DS) survival (Hazards Ratio, adj.HR=2.0. 1.0-3.9) and recurrence (adj.HR=3.6, 1.6-8.2); and HPV- cases had worse DS survival (adj.HR=2.8, 1.1-7.1) and recurrence (adj.HR=2.0, 0.8-4.8) compared to HPV-HR patients. Each of the p16/HPV groups had different survival outcomes: p16+/HPV-HR cases (referent) had the best and p16-/HPV- cases had the worst DS survival (adj.HR=3.6; 53% versus 13%, p=0.004) whereas p16+/HPV- and p16-/HPV-HR had similar DS survival (adj.HR=2.7/2.8). p16-/HPV-HR cases had a worse recurrence rate (adj.HR=7.0; 60% versus 0%, referent, p=0.08) than p16-/HPV- (adj.HR=4.5) or p16+/HPV- (adj.HR=1.8) cases. The combined p16/HPV biomarker data are associated with different survival outcomes of HNC compared to each marker evaluated separately, indicating that the two molecular mechanisms evaluated together may provide a more accurate prediction of clinical outcomes.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
joejo1124完成签到 ,获得积分10
1秒前
sl发布了新的文献求助10
2秒前
hhh发布了新的文献求助10
2秒前
爱吃藕粉凉羹的奶油完成签到,获得积分20
3秒前
动听煎饼完成签到 ,获得积分10
4秒前
明理冬瓜完成签到,获得积分10
4秒前
bkagyin应助cldg采纳,获得10
4秒前
小马甲应助不站在雾里采纳,获得10
4秒前
pp完成签到 ,获得积分0
5秒前
zhangjianzeng完成签到 ,获得积分10
5秒前
史小菜应助云轩采纳,获得20
6秒前
伏伏雅逸发布了新的文献求助10
6秒前
李健应助荒野风采纳,获得10
7秒前
Popeye应助单纯血茗采纳,获得10
7秒前
淡然冬灵发布了新的文献求助10
7秒前
Popeye应助单纯血茗采纳,获得10
7秒前
荔枝的油饼iKun完成签到,获得积分10
8秒前
Bosen完成签到,获得积分10
8秒前
Astraeus完成签到 ,获得积分10
9秒前
fengyuenanche完成签到,获得积分10
10秒前
五虎完成签到,获得积分10
11秒前
Akim应助Rollei采纳,获得10
12秒前
hoshi1018完成签到,获得积分10
13秒前
友好曲奇完成签到,获得积分10
13秒前
dongdong完成签到 ,获得积分10
14秒前
CR7完成签到,获得积分0
15秒前
左丘忻完成签到,获得积分10
15秒前
凤迎雪飘完成签到,获得积分10
15秒前
15秒前
FashionBoy应助云轩采纳,获得10
16秒前
领导范儿应助伏伏雅逸采纳,获得10
16秒前
17秒前
Rondab应助悦耳荟采纳,获得10
17秒前
liqian完成签到,获得积分10
17秒前
易安发布了新的文献求助100
18秒前
19秒前
完美世界应助科研通管家采纳,获得10
19秒前
852应助科研通管家采纳,获得10
19秒前
今后应助科研通管家采纳,获得10
19秒前
高分求助中
【提示信息,请勿应助】关于scihub 10000
Les Mantodea de Guyane: Insecta, Polyneoptera [The Mantids of French Guiana] 3000
徐淮辽南地区新元古代叠层石及生物地层 3000
The Mother of All Tableaux: Order, Equivalence, and Geometry in the Large-scale Structure of Optimality Theory 3000
Global Eyelash Assessment scale (GEA) 1000
Picture Books with Same-sex Parented Families: Unintentional Censorship 550
Research on Disturbance Rejection Control Algorithm for Aerial Operation Robots 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 4038446
求助须知:如何正确求助?哪些是违规求助? 3576149
关于积分的说明 11374627
捐赠科研通 3305875
什么是DOI,文献DOI怎么找? 1819354
邀请新用户注册赠送积分活动 892680
科研通“疑难数据库(出版商)”最低求助积分说明 815048